title: Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy.
authors.affiliation: Division of Transplant Surgery, Leicester General Hospital, Cuenden Road, Leicester LE5 4PW, United Kingdom.
authors.forename: J R
authors.initials: JR
authors.lastname: Waller
authors.forename: G J
authors.initials: GJ
authors.lastname: Murphy
authors.forename: M S
authors.initials: MS
authors.lastname: Metcalfe
authors.forename: R M
authors.initials: RM
authors.lastname: Sandford
authors.forename: C J
authors.initials: CJ
authors.lastname: Pattenden
authors.forename: M L
authors.initials: ML
authors.lastname: Nicholson
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005355:Fibrosis / Q000517:prevention & control*; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus